NORWALK, Conn., Oct. 18, 2011 /PRNewswire-iReach/ -- This October, UBM Medica's Psychiatric Times (www.psychiatrictimes.com) features special coverage that focuses on the psychiatric treatment of children and adolescents, particularly the importance of a strong family-psychiatrist bond.
Mental disorders are relatively common among children in the United States. According to the National Institute of Health, over 20 percent of children have or have had a seriously debilitating mental disorder.
Topic highlights include:
- "Custody Disputes," which discusses the role of the child psychiatrist in custody battles. The wrangling is anxiety-provoking for the clinician as well as the children.
- "Familial Influences on Adolescent Substance Use" features data on the genetic and behavioral legacy of substance abuse.
- "The Psychiatrist's Role on the Pediatric Palliative Care Team" provides current data and case vignettes to illustrate three common — yet challenging — areas where psychiatrists must keep in mind the impending death of the child and the quality of life of the parents.
- "Psychiatric Issues in Children and Adolescents with Diabetes" emphasizes the importance of working together with family for improved treatment adherence in children with Type 1 diabetes mellitus. The authors suggest ways child psychiatrists can communicate with parents in order to optimize outcomes and assist their children in developmentally appropriate ways.
To improve adherence to treatment and strengthen outcomes, it is imperative for parents and their child's clinicians to develop a strong relationship. "Child and adolescent psychiatrists play an integral role in successful outcomes for their young patients," says Laura Prager, MD, Director of the Child Psychiatry Emergency Service at the Massachusetts General Hospital in Boston and regular Psychiatric Times contributor. "Without such an alliance with caregivers, the treatment will likely fail and the child will suffer."
Providing unbiased, objective coverage, Psychiatric Times reports on the latest clinical developments in the field of psychiatry, including the areas of child & adolescent psychiatry
About UBM Medica
Addressing today's healthcare information needs, UBM Medica, a division of UBM plc (UBM.L), delivers strategic, integrated communications solutions and comprehensive reach—online, in print, live, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, drug databases, data services, live events , and other valuable resources, UBM Medica also delivers comprehensive communication solutions for the pharmaceutical and related industries. US websites include PsychiatricTimes.com, CancerNetwork.com, DiagnosticImaging.com, ConsultantLive.com, OBGYN.net, PhysiciansPractice.com and SearchMedica.com. Employing more than 1,400 people with offices in 29 countries, UBM Medica is headquartered in London. For more information, visit http://www.ubmmedica.com/.
Director of Marketing
News distributed by PR Newswire iReach: https://ireach.prnewswire.com Related medicine technology :1
. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities2
. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting3
. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting4
. Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidones Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events5
. Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting6
. CNS Response, Inc. Provides Review of Poster Session Delivered at the American Psychiatric Association 161st Annual Meeting7
. Ridge Diagnostics, Inc. Clinical Data on Blood Test for Depression Presented at American Psychiatric Association Annual Meeting8
. Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases9
. Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 3010
. Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders11
. FDA Approves NDA That Includes Psychiatric Data Collected by Centralized Raters